MBMR Biolabs offers products in bio-orthogonal chemistry.
MBMR Biolabs offers inverse-electron demand diels-alder cycloaddition between trans-cyclooctenes and tetrazines that is biocompatible. Their applications have been developed that utilise tetrazine cycloaddition to image and retrieve nucleic acids, proteins, glycans, lipids, and other metabolites in vitro, in cells as well as in whole organisms.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 22, 2012 | Grant | $499.82K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |